Allscripts to sell budgeting, analytics business Epsi for $365M

” By bringing these two exceptional business together, our company believe that we can build among the most crucial business in helping to fix the biggest problem in healthcare: the expense of it,” said Dan Michelson, CEO of Strata. “Our focus will be to accelerate innovation to provide more comprehensive and deeper solutions to help our clients, provide the greatest service levels in the market, and create the extremely best place to operate in health care.”.

Epsi offers monetary choice support and preparation tools for medical facilities and health systems while Strata provides a cloud-based financial analytics platform for health care monetary planning and decision support. The software application businesss consumer base consists of more than 220 healthcare delivery systems.

The transaction is expected to close later this year, based on regulatory approval and traditional closing conditions. The 2 companies will continue to run individually till the deal closes, when Epsis client base and associates will then transition to Strata.

” This contract is a triple win for EPSi customers and Allscripts shareholders as it enables us to effectively recirculate capital, increase our concentrate on our core companies, and bring our EPSi clients the benefit of ongoing investment under new and extremely strong ownership,” Allscripts CFO Rick Poulton said in the news release.

Jackie Drees –
Thursday, July 30th, 2020

Allscripts revealed July 30 that Strata Decision Technology will acquire its health care choice analytics and budgeting company Epsi for $365 million.

More posts on EHRs: Change Healthcare releases cloud-based client records retrieval service: 4 notesOchsner St. Mary completes $6M Epic EHR install: 4 notes16 hospitals, health systems seeking Allscripts, Cerner, Epic, Meditech talent.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by clicking here.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material? View our policies by click on this link.